Neurogene, Inc. (NGNE)
24.30
+0.37
(+1.55%)
USD |
NASDAQ |
Nov 16, 10:27
Neurogene Price to Book Value : 1.417 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.396 |
| November 12, 2026 | 1.394 |
| November 11, 2026 | 1.464 |
| November 10, 2026 | 1.474 |
| November 09, 2026 | 1.516 |
| November 06, 2026 | 1.476 |
| November 05, 2026 | 1.496 |
| November 04, 2026 | 1.609 |
| November 03, 2026 | 1.556 |
| November 02, 2026 | 1.552 |
| October 30, 2026 | 1.607 |
| October 29, 2026 | 1.681 |
| October 28, 2026 | 1.774 |
| October 27, 2026 | 1.574 |
| October 26, 2026 | 1.373 |
| October 23, 2026 | 1.374 |
| October 22, 2026 | 1.416 |
| October 21, 2026 | 1.521 |
| October 20, 2026 | 1.482 |
| October 19, 2026 | 1.410 |
| October 16, 2026 | 1.356 |
| October 15, 2026 | 1.397 |
| October 14, 2026 | 1.294 |
| October 13, 2026 | 1.258 |
| October 12, 2026 | 1.426 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.540 |
| October 08, 2026 | 1.546 |
| October 07, 2026 | 1.509 |
| October 06, 2026 | 1.484 |
| October 05, 2026 | 1.544 |
| October 02, 2026 | 1.496 |
| October 01, 2026 | 1.548 |
| September 30, 2026 | 1.623 |
| September 29, 2026 | 2.070 |
| September 28, 2026 | 2.076 |
| September 25, 2026 | 2.064 |
| September 24, 2026 | 2.278 |
| September 23, 2026 | 2.255 |
| September 22, 2026 | 2.450 |
| September 21, 2026 | 2.375 |
| September 18, 2026 | 2.340 |
| September 17, 2026 | 2.363 |
| September 16, 2026 | 2.528 |
| September 15, 2026 | 2.456 |
| September 14, 2026 | 2.567 |
| September 11, 2026 | 2.587 |
| September 10, 2026 | 2.633 |
| September 09, 2026 | 2.762 |
| September 08, 2026 | 2.780 |
| September 04, 2026 | 2.814 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.376 |
| Alnylam Pharmaceuticals, Inc. | 5.977 |
| Anika Therapeutics, Inc. | 1.272 |
| Savara, Inc. | 8.671 |
| Arrowhead Pharmaceuticals, Inc. | 128.78 |
Price to Book Value Related Metrics
| PEG Ratio | -0.1707 |
| Price | 24.30 |
| Earnings Yield | -22.88% |
| Market Cap | 502.85M |
| PEGY Ratio | -0.1707 |